V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012812 | 160006186 | 1.56 | 81 | Adjuvant (A) | 2019-09-03 | 2019-09-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100820307 |
| 160012814 | 160006187 | 0 | 18 | Palliative (P) | 2016-11-20 | 2016-11-26 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100644047 |
| 160012816 | 160006188 | 1.81 | 113.1 | null | 2019-06-06 | 2019-07-02 | Pemetrexed | Y | N | EURO-EWING | 101726139 |
| 160012817 | 160006189 | 0 | 17.8 | 02 | 2018-07-27 | 2018-08-04 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 100952379 |
| 160012818 | 160006190 | 1.77 | 80 | Palliative (P) | 2018-08-03 | 2018-08-10 | Paclitaxel 7 day | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101161270 |
| 160012819 | 160006191 | 1.77 | 95.3 | Palliative (P) | 2016-07-14 | 2016-07-24 | Doxorubicin + Ifosfamide | N | N | CARBOPLATIN + ETOPOSIDE | 101236162 |
| 160012823 | 160006192 | 1.7 | 118 | Palliative (P) | 2017-12-02 | 2017-12-23 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | Y | PEMETREXED | 101801799 |
| 160012826 | 160006194 | 0.7 | 82.9 | Palliative (P) | 2020-09-29 | 2020-09-29 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100766426 |
| 160012827 | 160006195 | 1.69 | 73.2 | Curative (C) | 2018-10-06 | 2018-12-04 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | CARBOPLATIN + GEMCITABINE | 100615569 |
| 160012828 | 160006196 | 1.71 | 51 | null | 2017-03-28 | 2017-03-28 | Liposomal Doxorubicin (Caelyx) | N | N | DOXORUBICIN + OLARATUMAB | 100691748 |
| 160012829 | 160006197 | 1.82 | 86.6 | null | 2016-03-13 | 2016-03-20 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100713993 |
| 160012830 | 160006198 | 0 | 0 | Palliative (P) | 2018-08-27 | 2018-09-04 | STS Non-Rhabdo EpSSG 2005 IVA | N | N | CAPECITABINE | 101446183 |
| 160012832 | 160006199 | null | 62.1 | Palliative (P) | 2018-12-18 | 2019-01-13 | Liposomal Doxorubicin (Caelyx) | 02 | N | ENZALUTAMIDE | 101370761 |
| 160012833 | 160006200 | 1.86 | 97.9 | Neo-adjuvant (N) | 2016-11-04 | 2016-12-15 | Cisplatin + Pemetrexed | null | 2 | CISPLATIN + PEMETREXED | 100089443 |
| 160012834 | 160006201 | 0 | 34 | Neo-adjuvant (N) | null | 2017-01-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100180625 |
| 160012835 | 160006202 | 1.65 | 83.6 | Neo-adjuvant (N) | 2018-06-06 | 2018-06-10 | Bevacizumab+Carbo+Pacliaxel | N | N | ATOMIC-MESO TRIAL | 101506518 |
| 160012836 | 160006203 | null | null | Palliative (P) | 2016-09-26 | 2016-10-03 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101799056 |
| 160012837 | 160006204 | 1.65 | 90 | Curative (C) | 2018-10-17 | 2018-11-16 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101285921 |
| 160012838 | 160006205 | 1.73 | 63 | Palliative (P) | 2019-10-10 | 2019-10-10 | ETOPOSIDE + IFOSFAMIDE | 02 | N | DOXORUBICIN | 100702533 |
| 160012840 | 160006206 | null | null | null | 2019-12-31 | 2020-01-14 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101536920 |
| 160012841 | 160006207 | 1.72 | 63.5 | Palliative (P) | 2019-12-12 | 2019-12-26 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101031041 |
| 160012844 | 160006208 | 1.62 | 73 | Palliative (P) | 2016-12-30 | 2017-01-02 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101767613 |
| 160012845 | 160006209 | 1.6 | 82.2 | Palliative (P) | 2016-07-06 | 2016-07-06 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 100198972 |
| 160012846 | 160006210 | 0 | 57.7 | null | 2017-06-27 | 2017-07-12 | Doxorubicin + Ifosfamide | 02 | null | IVA | 101422751 |
| 160012847 | 160006211 | 1.78 | 77 | Palliative (P) | null | 2017-02-05 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101819231 |
| 160012850 | 160006212 | 0 | 0 | Palliative (P) | 2020-03-26 | 2020-03-26 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101476965 |
| 160012854 | 160006213 | 1.75 | 95.7 | Curative (C) | 2018-10-16 | 2018-10-16 | EW EuroEwing 2012 Arm A VIDE | 02 | N | GC INT GUIDE EXCRANIAL GERMCELL JEB | 100762618 |
| 160012856 | 160006214 | 1.76 | 71 | Palliative (P) | 2017-07-03 | 2017-07-15 | Doxorubicin 75mg/m2 | 01 | N | DOXORUBICIN | 101511551 |
| 160012857 | 160006215 | 1.78 | 72 | Palliative (P) | 2020-05-15 | 2020-05-23 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100952672 |
| 160012862 | 160006216 | 1.81 | 86.3 | 02 | 2018-07-09 | 2018-07-27 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101238666 |
| 160012863 | 160006217 | 1.55 | 81.4 | Palliative (P) | null | 2015-12-05 | VIDE | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101524686 |
| 160012864 | 160006218 | 1.81 | 92 | Palliative (P) | 2017-07-06 | 2017-07-28 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101182233 |
| 160012865 | 160006219 | 1.7 | 64.7 | Palliative (P) | 2018-07-24 | 2018-08-01 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 101439407 |
| 160012866 | 160006220 | 1.84 | 74.8 | Palliative (P) | 2019-11-08 | 2020-01-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100623709 |
| 160012867 | 160006221 | 1.58 | 84.9 | Palliative (P) | 2022-05-26 | 2022-05-29 | IVADo | 02 | N | PEMETREXED | 100665072 |
| 160012869 | 160006222 | 1.72 | 60.9 | Curative (C) | 2018-11-11 | 2018-11-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100945438 |
| 160012870 | 160006223 | 1.81 | 70 | null | 2016-03-07 | 2016-03-07 | Bevacizumab 7.5mg/kg | 02 | null | CISPLATIN + PEMETREXED | 100842028 |
| 160012871 | 160006224 | 0 | 18.2 | Palliative (P) | 2016-06-10 | 2016-06-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101539807 |
| 160012872 | 160006225 | 1.67 | 71.05 | Palliative (P) | 2017-02-05 | 2017-02-06 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100743013 |
| 160012878 | 160006226 | 1.58 | 50 | Curative (C) | 2017-04-19 | 2017-04-20 | IBRUTINIB | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 101379210 |
| 160012880 | 160006227 | 1.74 | 80.9 | Neo-adjuvant (N) | 2017-11-20 | 2017-11-24 | Trial Unspecified | N | N | TRIAL UNSPECIFIED | 101734027 |
| 160012881 | 160006228 | 1.66 | 88 | null | 2019-04-25 | 2019-04-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100048360 |
| 160012884 | 160006229 | 1.7 | 87.1 | Palliative (P) | 2019-03-04 | 2019-03-11 | null | 02 | N | NOT MATCHED | 101005268 |
| 160012885 | 160006230 | null | null | Palliative (P) | 2017-11-08 | 2017-11-08 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101867948 |
| 160012886 | 160006231 | 1.51 | 84.2 | Palliative (P) | 2018-01-31 | 2018-01-31 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101126319 |
| 160012887 | 160006232 | 1.88 | 85.6 | Palliative (P) | 2017-07-09 | 2017-07-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100807486 |
| 160012890 | 160006233 | 1.74 | 88.7 | Palliative (P) | 2018-10-04 | 2018-10-18 | Doxorubicin + Ifosfamide | 01 | N | TRIAL UNSPECIFIED | 101580387 |
| 160012891 | 160006234 | 1.81 | 73.7 | Palliative (P) | 2017-06-21 | 2017-07-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101578003 |
| 160012892 | 160006235 | 1.55 | 79.8 | null | 2019-11-28 | 2019-12-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100647666 |
| 160012897 | 160006237 | null | null | Palliative (P) | 2018-03-23 | 2018-03-26 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101530278 |